Dr. Reddy's US Subsidiary Incurs Minor Penalty From US IRS
Dr Reddys Laboratories Ltd · Others (Uncategorized) · 03 Oct 2026, 10:40 pm
Dr. Reddy's US Subsidiary Incurs Minor Penalty From US IRS Dr. Reddy’s Laboratories announced that its step-down wholly owned subsidiary, Dr. Reddy’s Laboratories, Inc., received a transcript dated 25th Sep'26 from the US Internal Revenue Service on 2nd Oct'26 levying a penalty of $32,350.20. The penalty was imposed due to a misclassification of the fiscal year reference during tax payment. The company confirmed that the levy has no material impact on its financial position, operations, or broader business activities.
Original exchange filing (PDF)
More announcements from Dr Reddys Laboratories Ltd
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 · 14 Nov 2026
- Intimation of Analyst meet · 11 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 · 05 Nov 2026
- Allotment of Employee Stock options · 04 Nov 2026
- Clarification - Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 · 04 Nov 2026
- The Exchange has sought Clarification from Dr Reddys Laboratories Ltd with reference to the media report appearing on https://www.firstpost.com dated November 03, 2026 (Link : https://www.firstpost.com/business/indias-dr-reddys-gets-us-nod-for-40-generic-hiv-prevention-shot-for-120-poorer-countries-14057224.html) .... · 03 Nov 2026
- Transcript of Earnings call · 30 Oct 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 · 28 Oct 2026
